Benzinga | Aug 10, 2020 07:59AM EDT

WAVE Life Sciences Q2 EPS $(1.15) Misses $(0.97) Estimate, Sales $3.03M Miss $5.65M Estimate

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(1.15) per share which missed the analyst consensus estimate of $(0.97) by 18.56 percent. This is a 5.74 percent increase over losses of $(1.22) per share from the same period last year. The company reported quarterly sales of $3.03 million which missed the analyst consensus estimate of $5.65 million by 46.42 percent. This is a 60.32 percent decrease over sales of $7.63 million the same period last year.